All Posts:lymphoma
-
Remission of Follicular Lymphoma for Two-Plus Years Indicates Disease-Free Status that Could Be Lifelong
Use of next-generation sequencing provides evidence of no detectable lymphoma in these patients. Media Contact Karen Teberkm463@georgetown.edu ATLANTA (December 8, 2019) — People with f
Category: News Release
-
Carnegie Renews Classification of Georgetown as ‘Very High Research University’
Georgetown has once again been classified by the Carnegie Classification of Institutions of Higher Education as an institution with “very high research activity.”
Category: Lombardi Stories
-
First Patient in a Clinical Trial Using Her Own Blood to Personalize Treatment for Non-Hodgkin Lymphoma Experiencing Remission
The first cancer patient to be treated as part of the CAR-T cell clinical trial at MedStar Georgetown University Hospital through Georgetown Lombardi Comprehensive Cancer Center, a mother of two and grandmother of four, is now in “complete remission” after a lengthy battle with stage-three non-Hodgkin lymphoma.
Category: Lombardi Stories